Showing results (41-50 of 59) with videos related to
Sort By:
Pageof 6
Nephrologie & Therapeutique|February 15, 2011
[Plasma malondialdehyde may not predict mortality in patient with chronic kidney disease]Aurélie Terrier-Lenglet, Aude Nollet, Sophie Liabeuf, et al.Clinical Kidney Journal|November 8, 2016
The clinical impact of plasma leptin levels in a cohort of chronic kidney disease patientsRodrigo Bueno de Oliveira, Sophie Liabeuf, Hirokazu Okazaki, et al.Plos One|March 19, 2013
The "artificial artery" as in vitro perfusion modelDoreen Janke, Joachim Jankowski, Marieke Rüth, et al.Molecular Cancer Therapeutics|May 30, 2006
Experimental therapy of malignant gliomas using the inhibitor of histone deacetylase MS-275Ilker Y Eyüpoglu, Eric Hahnen, Christian Tränkle, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 15, 2011
Costimulatory protein 4IgB7H3 drives the malignant phenotype of glioblastoma by mediating immune escape and invasivenessDieter Lemke, Philipp-Niclas Pfenning, Felix Sahm, et al.Journal of Hypertension|March 2, 2011
Markers of vascular disease in plasma from patients with chronic kidney disease identified by proteomic analysisEric Schiffer, Sophie Liabeuf, Chrystelle Lacroix, et al.Journal of Neuro-Oncology|November 29, 2019
cMyc and ERK activity are associated with resistance to ALK inhibitory treatment in glioblastomaAnne Berberich, Lara-Marie Schmitt, Stefan Pusch, et al.Frontiers in Oncology|June 26, 2020
LAPTM5-CD40 Crosstalk in Glioblastoma Invasion and Temozolomide ResistanceAnne Berberich, Frederik Bartels, Zili Tang, et al.Acta Oncologica (Stockholm, Sweden)|April 19, 2011
Clinical outcome with bevacizumab in patients with recurrent high-grade glioma treated outside clinical trialsSilvia Hofer, Katarzyna Elandt, Richard Greil, et al.Oncotarget|July 23, 2016
Slowing down glioblastoma progression in mice by running or the anti-malarial drug dihydroartemisinin? Induction of oxidative stress in murine glioblastoma therapyDieter Lemke, Hans-Werner Pledl, Markus Zorn, et al.Pageof 6